title: Antibiotic resistance--what can we do?
authors.affiliation: SmithKline Beecham Pharmaceuticals, Harlow, Essex, UK.
authors.forename: R P
authors.initials: RP
authors.lastname: Bax
authors.forename: R
authors.initials: R
authors.lastname: Anderson
authors.forename: J
authors.initials: J
authors.lastname: Crew
authors.forename: P
authors.initials: P
authors.lastname: Fletcher
authors.forename: T
authors.initials: T
authors.lastname: Johnson
authors.forename: E
authors.initials: E
authors.lastname: Kaplan
authors.forename: B
authors.initials: B
authors.lastname: Knaus
authors.forename: K
authors.initials: K
authors.lastname: Kristinsson
authors.forename: M
authors.initials: M
authors.lastname: Malek
authors.forename: L
authors.initials: L
authors.lastname: Strandberg
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001424:Bacterial Infections / Q000517:prevention & control*; D002986:Clinical Trials as Topic; D016208:Databases, Factual; D004352:Drug Resistance, Microbial; D006287:Health Planning Guidelines; D012107:Research Design
chemical_list: D000900:Anti-Bacterial Agents